The superior immunosuppressant according to diagnosis: FK 506 or cyclosporine A.
Mueller
A R
AR
Department of Surgery, Free University of Berlin, Germany.
Platz
K P
KP
Blumhardt
G
G
Bechstein
W O
WO
Steinmüller
T
T
Christe
W
W
Hopf
U
U
Lobeck
H
H
Neuhaus
P
P
D000208:Acute Disease; D016572:Cyclosporine / Q000009:adverse effects / Q000097:blood / Q000627:therapeutic use*; D016903:Drug Monitoring; D006084:Graft Rejection / Q000453:epidemiology / Q000276:immunology; D006801:Humans; D007165:Immunosuppression Therapy / Q000379:methods; D015994:Incidence; D016031:Liver Transplantation / Q000276:immunology* / Q000401:mortality; D015996:Survival Rate; D016559:Tacrolimus / Q000009:adverse effects / Q000627:therapeutic use*; D013997:Time Factors
D016572:Cyclosporine; D016559:Tacrolimus